PainReform (NASDAQ: PRFX)
$2.04
(3.8%)
$0.08
Price as of June 10, 2025, 3:59 p.m. ET
PainReform Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
PainReform Company Info
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. It offers PRF-110, an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized and extended post-operative analgesia. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.